[胰腺神经内分泌瘤的新辅助疗法:目前的状况和未来的方向]
1Department of General Surgery, Qilu Hospital, Shandong University, Jinan 250012, China.
Zhonghua wai ke za zhi [Chinese journal of surgery]
|November 26, 2025
概括
新辅助疗法在胰腺神经内分泌瘤 (PNEN) 方面表现有前途,通过改善外科手术结果. 需要进一步的研究来规范其使用,并优化患者的治疗,以提高生存率.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 胰腺神经内分泌瘤 (PNENs) 是一组多样化的瘤,其行为有变化.
- 治疗策略必须考虑个体患者和瘤特征.
研究的目的:
- 系统地审查PNENs的新辅助疗法.
- 检查患者选择,治疗方案优化,反应评估和手术时间.
主要方法:
- 审查当代指南和新兴文学.
- 对新辅助疗法在瘤下降阶段和R0切除率中的作用的分析.
主要成果:
- 新辅助疗法在PNEN中缺乏研究,临床证据有限.
- 在标准化PNENs的新辅助方法方面存在挑战.
结论:
- 多中心前性研究对于建立新辅助PNEN管理的高水平证据至关重要.
- 人工智能和精准医学可能会个性化未来的PNEN治疗模式.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
527
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
527
Chronic Pancreatitis II: Collaborative Care
296
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
296
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K

